tirzepatide vs semaglutide efficacy side effects for Weight Loss in Adults With Overweight or Obesity Cardiovascular outcomes of semaglutide and

Liu C, Cao M, Yang N, Reid-Adam J, Tversky J, Zhan J, et al

If you want to start losing weight now, semaglutide is already available and can help you lose a significant amount of weight

Following the FDA approval in late 2025, oral semaglutide for weight loss began rolling out to retail pharmacies across the United States as of early 2026

Retatrutide is an investigational triple receptor agonist currently in clinical trials for obesity and type 2 diabetes

For many patients, lifestyle plus pharmacotherapy outperforms either alone

The result is weight regain leading to the recurrence of pre-diabetes, hypertension, dyslipidemia, and other risks , and essentially wasted effort, cost, and time